Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 228-231, January 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, T.
Right arrow Articles by Pommier, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, T.
Right arrow Articles by Pommier, Y.

Unscheduled Activation of Cyclin B1/Cdc2 Kinase in Human Promyelocytic Leukemia Cell Line HL60 Cells Undergoing Apoptosis Induced by DNA Damage

Tsunehiro Shimizu, Patrick M. O'Connor, Kurt W. Kohn and Yves Pommier1

Laboratory of Molecular Pharmacology, Division of Cancer Treatment, Developmental Therapeutics Program, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255

We have studied changes in cyclin A- and B1-dependent kinases during apoptosis induced in human promyelocytic leukemia (HL60) cells treated with the topolsomerase I inhibitor camptothecin. We found that cyclin B1/Cdc2 kinase activity transiently increases within 30 min after camptothecin treatment. This increase is followed by a rapid inactivation of the cyclin B1/Cdc2 kinase that is associated with Cdc2 tyrosine phosphorylation without any change in Cdc2 or cyclin B1 protein levels. The DNA polymerase inhibitor aphidicolin abrogates camptothecin-induced changes in cyclin B1/Cdc2 kinase activity, indicating that DNA replication-induced DNA damage is essential for both Cdc2 alterations and apoptosis activation. Apoptosis and the initial cyclin B1/Cdc2 kinase activation were amplified using synchronized S-phase cells, and cyclin A/cdk2 kinase did not change under these conditions. The same transient activation and subsequent inactivation of cyclin B1/Cdc2 kinase were observed after DNA damage by etoposide or bis-(2-chloroethyl)methylamine hydrochloride. These observations suggest that DNA damage promotes the transient and unscheduled stimulation of cyclin B1/Cdc2 kinase activity in HL60 cells prior to apoptosis.

1 To whom requests for reprints should be addressed, at Laboratory of Molecular Pharmacology, NCI, Bldg. 37, Rm. 5C25, NIH, Bethesda, MD 20892-4255.

Received 10/24/94. Accepted 12/ 1/94.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
W. Liu, W. Li, T. Fujita, Q. Yang, and Y. Wan
Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis
Carcinogenesis, February 1, 2008; 29(2): 263 - 272.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X.-Y. Pei, W. Li, Y. Dai, P. Dent, and S. Grant
Dissecting the Roles of Checkpoint Kinase 1/CDC2 and Mitogen-Activated Protein Kinase Kinase 1/2/Extracellular Signal-Regulated Kinase 1/2 in Relation to 7-Hydroxystaurosporine-Induced Apoptosis in Human Multiple Myeloma Cells
Mol. Pharmacol., December 1, 2006; 70(6): 1965 - 1973.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Bozko, M. Sabisz, A. K. Larsen, and A. Skladanowski
Cross-talk between DNA damage and cell survival checkpoints during G2 and mitosis: pharmacologic implications
Mol. Cancer Ther., December 1, 2005; 4(12): 2016 - 2025.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Takahashi, F. Yamasaki, T. Sudo, H. Itamochi, S. Adachi, M. Tamamori-Adachi, and N. T. Ueno
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity
Mol. Cancer Ther., July 1, 2005; 4(7): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X.-Y. Pei, Y. Dai, M. Rahmani, W. Li, P. Dent, and S. Grant
The Farnesyltransferase Inhibitor L744832 Potentiates UCN-01-Induced Apoptosis in Human Multiple Myeloma Cells
Clin. Cancer Res., June 15, 2005; 11(12): 4589 - 4600.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Hahn, W. Li, C. Yu, M. Rahmani, P. Dent, and S. Grant
Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways
Mol. Cancer Ther., March 1, 2005; 4(3): 457 - 470.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Jia, C. Yu, M. Rahmani, G. Krystal, E. A. Sausville, P. Dent, and S. Grant
Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways
Blood, September 1, 2003; 102(5): 1824 - 1832.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Yu, M. Rahmani, Y. Dai, D. Conrad, G. Krystal, P. Dent, and S. Grant
The Lethal Effects of Pharmacological Cyclin-dependent Kinase Inhibitors in Human Leukemia Cells Proceed through a Phosphatidylinositol 3-Kinase/Akt-dependent Process
Cancer Res., April 15, 2003; 63(8): 1822 - 1833.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. A. Porter, I. H. Cukier, and J. M. Lee
Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis
Blood, March 1, 2003; 101(5): 1928 - 1933.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Dai, T. H. Landowski, S. T. Rosen, P. Dent, and S. Grant
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism
Blood, October 16, 2002; 100(9): 3333 - 3343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. S. Levenson, K. M. Svoboda, K. M. Pease, S. A. Kaiser, B. Chen, L. A. Simons, B. D. Jovanovic, P. A. Dyck, and V. C. Jordan
Gene Expression Profiles with Activation of the Estrogen Receptor {alpha}-Selective Estrogen Receptor Modulator Complex in Breast Cancer Cells Expressing Wild-Type Estrogen Receptor
Cancer Res., August 1, 2002; 62(15): 4419 - 4426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Chiarini, J. F. Whitfield, U. Armato, and I. Dal Pra
Protein Kinase C-beta II Is an Apoptotic Lamin Kinase in Polyomavirus-transformed, Etoposide-treated pyF111 Rat Fibroblasts
J. Biol. Chem., May 17, 2002; 277(21): 18827 - 18839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Yu, G. Krystal, L. Varticovksi, R. McKinstry, M. Rahmani, P. Dent, and S. Grant
Pharmacologic Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase/Mitogen-activated Protein Kinase Inhibitors Interact Synergistically with STI571 to Induce Apoptosis in Bcr/Abl-expressing Human Leukemia Cells
Cancer Res., January 1, 2002; 62(1): 188 - 199.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. A. Shah and G. K. Schwartz
Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy
Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Dai, C. Yu, V. Singh, L. Tang, Z. Wang, R. McInistry, P. Dent, and S. Grant
Pharmacological Inhibitors of the Mitogen-activated Protein Kinase (MAPK) Kinase/MAPK Cascade Interact Synergistically with UCN-01 to Induce Mitochondrial Dysfunction and Apoptosis in Human Leukemia Cells
Cancer Res., July 1, 2001; 61(13): 5106 - 5115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X.-L. Ding, J. Husseman, A. Tomashevski, D. Nochlin, L.-W. Jin, and I. Vincent
The Cell Cycle Cdc25A Tyrosine Phosphatase Is Activated in Degenerating Postmitotic Neurons in Alzheimer's Disease
Am. J. Pathol., December 1, 2000; 157(6): 1983 - 1990.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Frade
Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones
J. Cell Sci., January 4, 2000; 113(7): 1139 - 1148.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Kao, W. G. McKenna, and R. J. Muschel
p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells
J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. JORQUERA and R. M. TANGUAY
Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis
FASEB J, December 1, 1999; 13(15): 2284 - 2298.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim
Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-beta 1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells
J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A.-T. Sane and R. Bertrand
Caspase Inhibition in Camptothecin-treated U-937 Cells Is Coupled with a Shift from Apoptosis to Transient G1 Arrest Followed by Necrotic Cell Death
Cancer Res., August 1, 1999; 59(15): 3565 - 3569.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Li, J. Fan, D. Banerjee, and J. R. Bertino
Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein
Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
D. S. Park, E. J. Morris, J. Padmanabhan, M. L. Shelanski, H. M. Geller, and L. A. Greene
Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents
J. Cell Biol., October 19, 1998; 143(2): 457 - 467.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Secchiero, L. Bertolaso, L. Casareto, D. Gibellini, M. Vitale, K. Bemis, A. Aleotti, S. Capitani, G. Franchini, R. C. Gallo, et al.
Human Herpesvirus 7 Infection Induces Profound Cell Cycle Perturbations Coupled to Disregulation of cdc2 and Cyclin B and Polyploidization of CD4+ T Cells
Blood, September 1, 1998; 92(5): 1685 - 1696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shimizu, C.-X. Cao, R.-G. Shao, and Y. Pommier
Lamin B Phosphorylation by Protein Kinase Calpha and Proteolysis during Apoptosis in Human Leukemia HL60 Cells
J. Biol. Chem., April 10, 1998; 273(15): 8669 - 8674.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. S. Park, E. J. Morris, L. Stefanis, C. M. Troy, M. L. Shelanski, H. M. Geller, and L. A. Greene
Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress
J. Neurosci., February 1, 1998; 18(3): 830 - 840.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. W. Parker, G. Kaur, W. Nieves-Neira, M. Taimi, G. Kohlhagen, T. Shimizu, M. D. Losiewicz, Y. Pommier, E. A. Sausville, and A. M. Senderowicz
Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol
Blood, January 15, 1998; 91(2): 458 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I Duband-Goulet, J. Courvalin, and B Buendia
LBR, a chromatin and lamin binding protein from the inner nuclear membrane, is proteolyzed at late stages of apoptosis
J. Cell Sci., January 5, 1998; 111(10): 1441 - 1451.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R.-G. Shao, C.-X. Cao, and Y. Pommier
Activation of PKCalpha Downstream from Caspases during Apoptosis Induced by 7-Hydroxystaurosporine or the Topoisomerase Inhibitors, Camptothecin and Etoposide, in Human Myeloid Leukemia HL60 Cells
J. Biol. Chem., December 12, 1997; 272(50): 31321 - 31325.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Vincent, G. Jicha, M. Rosado, and D. W. Dickson
Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer's Disease Brain
J. Neurosci., May 15, 1997; 17(10): 3588 - 3598.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. S. Park, E. J. Morris, L. A. Greene, and H. M. Geller
G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis
J. Neurosci., February 15, 1997; 17(4): 1256 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. McConkey and S Orrenius
Signal transduction pathways in apoptosis
Stem Cells, November 1, 1996; 14(6): 619 - 631.
[Abstract]


Home page
J. Cell Sci.Home page
W Ongkeko, D. Ferguson, A. Harris, and C Norbury
Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage
J. Cell Sci., January 8, 1995; 108(8): 2897 - 2904.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.